Electro-catalysis by immobilised human flavin-containing monooxygenase isoform 3 (hFMO3)

被引:21
|
作者
Castrignano, Silvia [1 ]
Sadeghi, Sheila J. [1 ]
Gilardi, Gianfranco [1 ]
机构
[1] Univ Turin, Dept Human & Anim Biol, I-10123 Turin, Italy
关键词
Flavin-containing monooxygenase; Glassy carbon electrode; Glutaraldehyde gel; Bovine serum albumin; GLASSY-CARBON ELECTRODE; ADENINE-DINUCLEOTIDE; N-OXYGENATION; FMO3; POLYMORPHISMS; SENSOR; CYTOCHROME-P450; SPECIFICITY; ENZYME;
D O I
10.1007/s00216-010-4014-z
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Human flavin-containing monooxygenases are the second most important class of drug-metabolizing enzymes after cytochromes P450. Here we report a simple but functional and stable enzyme-electrode system based on a glassy carbon (GC) electrode with human flavin-containing monooxygenase isoform 3 (hFMO3) entrapped in a gel cross-linked with bovine serum albumin (BSA) by glutaraldehyde. The enzymatic electrochemical responsiveness is characterised by using well-known substrates: trimethylamine (TMA), ammonia (NH3), triethylamine (TEA), and benzydamine (BZD). The apparent Michaelis-Menten constant (K'(M)) and apparent maximum current (I'(max)) are calculated by fitting the current signal to the Michaelis-Menten equation for each substrate. The enzyme-electrode has good characteristics: the calculated sensitivity was 40.9 +/- 0.5 mA mol(-1) Lcm(-2) for TMA, 43.3 +/- 0.1 mA mol(-1) Lcm(-2) for NH3, 45.2 +/- 2.2 mA mol(-1) Lcm(-2) for TEA, and 39.3 +/- 0.6 mA mol(-1) Lcm(-2) for BZD. The stability was constant for 3 days and the inter-electrode reproducibility was 12.5%. This is a novel electrochemical tool that can be used to investigate new potential drugs against the catalytic activity of hFMO3.
引用
收藏
页码:1403 / 1409
页数:7
相关论文
共 50 条
  • [21] Potential for drug interactions mediated by polymorphic flavin-containing monooxygenase 3 in human livers
    Shimizu, Makiko
    Shiraishi, Arisa
    Sato, Ayumi
    Nagashima, Satomi
    Yamazaki, Hiroshi
    DRUG METABOLISM AND PHARMACOKINETICS, 2015, 30 (01) : 70 - 74
  • [22] Interindividual differences of human flavin-containing monooxygenase 3: Genetic polymorphisms and functional variation
    Cashman, JR
    Zhang, J
    DRUG METABOLISM AND DISPOSITION, 2002, 30 (10) : 1043 - 1052
  • [23] Identification and functional analysis of common human flavin-containing monooxygenase 3 genetic variants
    Koukouritaki, Sevasti B.
    Poch, Mark T.
    Henderson, Marilyn C.
    Siddens, Lisbeth K.
    Krueger, Sharon K.
    VanDyke, Jonathan E.
    Williams, David E.
    Pajewski, Nicholas M.
    Wang, Tao
    Hines, Ronald N.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 320 (01): : 266 - 273
  • [24] Novel variants of the human flavin-containing monooxygenase 3 (FMO3) gene associated with trimethylaminuria
    Motika, Meike S.
    Zhang, Jun
    Zheng, Xueying
    Riedler, Kiersten
    Cashman, John R.
    MOLECULAR GENETICS AND METABOLISM, 2009, 97 (02) : 128 - 135
  • [25] Identification of active flavin-containing monooxygenase isoform 2 in human lung and characterization of expressed protein
    Krueger, SK
    Martin, SR
    Yueh, MF
    Pereira, CB
    Williams, DE
    DRUG METABOLISM AND DISPOSITION, 2002, 30 (01) : 34 - 41
  • [26] Survey of variants of human flavin-containing monooxygenase 3 (FMO3) and their drug oxidation activities
    Yamazaki, Hiroshi
    Shimizu, Makiko
    BIOCHEMICAL PHARMACOLOGY, 2013, 85 (11) : 1588 - 1593
  • [27] A physiological role for flavin-containing monooxygenase (FMO3) in humans?
    Mitchell, S. C.
    Smith, R. L.
    XENOBIOTICA, 2010, 40 (05) : 301 - 305
  • [28] MUTATIONS OF FLAVIN-CONTAINING MONOOXYGENASE 3 (FMO3) GENE IN JAPANESE COHORTS
    Shimizu, Makiko
    Nakakuki, Komei
    Yoda, Hiromi
    Hiratsuka, Masahiro
    Yamazaki, Hiroshi
    DRUG METABOLISM AND PHARMACOKINETICS, 2019, 34 (01) : S63 - S63
  • [29] Flavin-containing monooxygenase 3 (FMO3) role in busulphan metabolic pathway
    El-Serafi, Ibrahim
    Terelius, Ylva
    Abedi-Valugerdi, Manuchehr
    Naughton, Sean
    Saghafian, Maryam
    Moshfegh, Ali
    Mattsson, Jonas
    Potacova, Zuzana
    Hassan, Moustapha
    PLOS ONE, 2017, 12 (11):
  • [30] POSTNATAL EXPRESSION AND TISSUE DISTRIBUTION OF FLAVIN-CONTAINING MONOOXYGENASE 3 (FMO3)
    Xu, Zhen
    Yan, Bingfang
    DRUG METABOLISM AND PHARMACOKINETICS, 2018, 33 (01) : S83 - S83